An investigation on behalf of investors in Talis Biomedical Corporation (NASDAQ:TLIS) shares over potential wrongdoing at Talis Biomedical Corporation was announced.

San Diego, CA -- (SBWire) -- 11/05/2021 --Certain directors of Talis Biomedical Corporation are under investigation concerning potential breaches of fiduciary duties.

Investors who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Talis Biomedical directors breached their fiduciary duties and caused damage to the company and its shareholders.

Menlo Park, CA based Talis Biomedical Corporation operates as a molecular diagnostic company.

On or about February 12, 2021, Talis Biomedical Corporation (NASDAQ: TLIS) sold approximately 13.8 million shares of stock in its initial public stock offering (the "IPO") at $16 a share, raising nearly $221 million in new capital.

On August 10, 2021, Talis Biomedical Corporation (NASDAQ: TLIS)reported its 2nd quarter financial results. During the earnings call, it was disclosed that "In the near term, our development time lines have been extended by delays in the launching of our COVID-19 test and manufacturing scale."

Then, on August 30, 2021, Talis announced that its President, CEO, and Director resigned.

Shares of Talis Biomedical Corporation (NASDAQ: TLIS) declined to as low as $7.01 per share on August 19 and 20, 2021.

Those who purchased shares of Talis Biomedical Corporation (NASDAQ: TLIS) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.